In estrogen receptor α-positive breast cancer cells, Rovito et al., have demonstrated that DHEA inhibited cancer cell proliferation in a concentration-dependent manner, reaching an IC50 value of 0.8 μM after 96 h in MCF-7 cells [82]. This evidence concerns the gene ESR1 and breast carcinoma.